Semaglutides Alzheimers Trial Failure: Rethinking Molecular Targets Beyond Amyloid Abstract Novo Nordisks recent phase 3 trials of semaglutide in early Alzheimers disease failed to demonstrate meaningful cognitive benefits, despite initial optimism and some biomarker improvements
Garg notes
Convenience, Frequency, And Cost Injections Require syringes, safe disposal, and usually medical supervision Often weekly or monthly, depending on protocol Costs can add up with repeated clinic visits Nasal spray Takes a few seconds, wherever you are Easy to build into a daily routine No sharps, no office visit, and generally lower ongoing cost For many busy professionals, athletes, and biohackers, nasal sprays offer most of the benefits of injections with a lower barrier to consistent use
STYLE OF SPORT: How heavy are your clients that are taking GLP-1s
Additionally, the Trump administration announced agreements with Novo Nordisk and Eli Lilly in November 2025 that set the Medicare price for Ozempic at $245 for a 30-day supply, with beneficiary copays of $50 per month once the program takes effect
